Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bidirectional electrostatic MEMS-tunable VCSELs.
Simonsen A, Payandeh M, Engelberth Hansen S, Marchevsky A, Cheol Park G, Kumar Sahoo H, Semenova E, Hansen O, Yvind K. Simonsen A, et al. Among authors: payandeh m. Opt Lett. 2024 Feb 15;49(4):802-805. doi: 10.1364/OL.510273. Opt Lett. 2024. PMID: 38359186
Improvement in the clinical manifestations of interstitial lung disease following treatment with placental mesenchymal stromal cell extracellular vesicles in a patient with systemic sclerosis: A case report.
Assar S, Mohammadzadeh D, Norooznezhad AH, Payandeh M, Hassaninia D, Pournazari M, Soufivand P, Yarani R, Mansouri K. Assar S, et al. Among authors: payandeh m. Respir Med Case Rep. 2023 Oct 2;46:101923. doi: 10.1016/j.rmcr.2023.101923. eCollection 2023. Respir Med Case Rep. 2023. PMID: 37928415 Free PMC article.
Human papillomavirus maybe is a critical player in the regulation of chemoresistance related factors (P53, Rb, TWIST, Bcl-2, Bcl-XL, c-IAP2, cytochrome C, and caspase 3) in breast cancer.
Haghighi ZMS, Tabatabaei T, Rafigh M, Karampour R, Babaei F, Amjad ZS, Payandeh M, Roozgari M, Bayat M, Doroudian M, Moghoofei M, Nahand JS. Haghighi ZMS, et al. Among authors: payandeh m. Pathol Res Pract. 2023 Aug;248:154653. doi: 10.1016/j.prp.2023.154653. Epub 2023 Jun 28. Pathol Res Pract. 2023. PMID: 37454490
A randomized, double-blind, phase III, non-inferiority clinical trial comparing the efficacy and safety of TA4415V (a proposed Trastuzumab biosimilar) and Herceptin (Trastuzumab reference product) in HER2-positive early-stage breast Cancer patients.
Nodehi RS, Kalantari B, Raafat J, Ansarinejad N, Moazed V, Mortazavizadeh SMR, Hosseinzadeh M, Ghaderi B, Jenabian A, Qadyani M, Haghighat S, Allahyari A, Mirzania M, Seghatoleslami M, Payandeh M, Alikhasi A, Kafi H, Shahi F. Nodehi RS, et al. Among authors: payandeh m. BMC Pharmacol Toxicol. 2022 Jul 28;23(1):57. doi: 10.1186/s40360-022-00599-x. BMC Pharmacol Toxicol. 2022. PMID: 35902898 Free PMC article. Clinical Trial.
60 results